Skip to content
WorkingMomRx
Menu

Head-to-head

CoreAge Rx vs Willow

CoreAge Rx and Willow both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.

CoreAge Rx

Higher score

Ranked #1 · Grade A

Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

Visit CoreAge Rx
vs

Willow

Ranked #19 · Grade C

Best for: Working moms in one of its 36 states who want a fast, fully asynchronous start with the price visible up front, and who will budget above the headline because the fee can climb as the dose does.

Visit Willow

The verdict

Higher Rx-Readiness Score: CoreAge Rx

CoreAge Rx edges out Willow on the Rx-Readiness Score, 95 to 72 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

Willow is still a genuine option — the async standout: no video visit, no quiz wall, prices posted in the open, and needle-free tablets alongside the injections — but the headline price is a starting dose, not a flat rate, and only 36 states are in. Weigh the six readiness factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx Willow
Time to first dose9580
CoreAge
Willow
Flat, predictable pricing9748
CoreAge
Willow
No-video (async) intake9592
CoreAge
Willow
Nationwide access9662
CoreAge
Willow
Both molecules on one plan9592
CoreAge
Willow
Easy off-ramp9258
CoreAge
Willow

Price, access & features

DetailCoreAge RxWillow
Rx-Readiness Score95/100 · A72/100 · C
Overall rank#1#19
Semaglutide$149/mo$299/mo
Tirzepatide$349/mo$399/mo
CoverageAll 50 states36 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes

CoreAge Rx

Ranked #1 · Grade A

What we like

  • Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
  • Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
  • Async, no-video intake and all-50-states coverage — start it during a lunch break

The caveats

  • Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
  • Compounded only — no FDA-approved brand option
  • General metabolic program, not a boutique concierge service

Willow

Ranked #19 · Grade C

What we like

  • Genuinely async — a short online form, no video appointment, and same-day physician review
  • Prices are public before intake, which is rarer in this field than it should be
  • Both molecules, and both as injections and needle-free tablets, on one account

The caveats

  • December 2025: after a challenge by Novo Nordisk, the National Advertising Division found Willow had not substantiated its compounded-semaglutide safety and efficacy claims and referred it to the FTC and state regulators (NAD case #7488). Willow reports discontinuing the claims since; the referral itself is a matter of record
  • Not flat pricing — the FAQ says costs vary by dosage and the Terms allow the fee to rise on a dose increase, with no tier table published
  • 36 states only, so fourteen states can't use it at all

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and Willow against other providers on our shortlist.

Or browse the full comparison hub.